Video Transcript - Hear about Kami’s experience with VRAYLAR® (cariprazine) Skip to Main Content VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. SELECT CONDITION Major Depressive Disorder Bipolar I Disorder Other Condition Important Safety Information Prescribing Information Medication Guide Cost & Savings Healthcare Professional Site Sign up for support See savings* About VRAYLAR How could VRAYLAR help? How does VRAYLAR work? How do I take VRAYLAR? Hear from a real VRAYLAR patient What are the possible side effects? Looking for a way to help break through to relief? Managing depression How common is depression? Common depression symptoms Watch real MDD patient stories Depression symptom tracker Understanding treatment options Add-on treatments Support & resources Save on VRAYLAR Track your mood & symptoms Find a support group Share your VRAYLAR story Resources for starting VRAYLAR Faq s Connect with a healthcare provider Sign up for support social fb insta youtube Healthcare Professional site EN ESPAÑOL Kami's experience with VRAYLAR Text on screen VRAYLAR USE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder in adults. Individual results may vary. Please see Safety Considerations at the end of this video. Stay tuned for Kami’s story on how she manages major depressive disorder (commonly referred to as depression). Text on screen Kami Living with major depressive disorder VO: My name is Kami. I live in West Virginia. I'm a super proud mom of my little girl and I was diagnosed with major depressive disorder. VO: The most important thing in my world is Elodie number one and then my family. We've always all been close. VO: I was a teenager when I first started noticing that something wasn't right. Not wanting to get out of bed, not wanting to be around anybody, I wanted to isolate myself. VO: It was getting to the point where I couldn't handle the symptoms on my own. I had to seek professional help. VO: When I went to the doctor, I was diagnosed with major depressive disorder. VO: I took quite a few years to find a treatment plan that worked for me. Quite a few different doctors. I felt like they weren't listening to what I was saying. The doctor I have now, we'll talk through things. We work together on it. And we decided on the medicine together. VO: I was taking an antidepressant and it was helping my symptoms, but it wasn't taking care of all the symptoms I was having. And I was still having my down days. That's when I went back to the doctor. VO: My doctor added VRAYLAR to also help manage my depression. Text on screen VRAYLAR added to an antidepressant has been shown to help reduce overall depression symptoms, on average, better than an antidepressant alone. Observed in 6- and 8-week studies. Individual results may vary. VO: VRAYLAR plus my antidepressant helped me treat my depression symptoms. VO: Now that my symptoms are better controlled I can navigate through life a little bit better. VO: Other than medicine, I journal a lot. Journaling helps me get it out of my head. I handwrite every day my thoughts and what's going on in life. VO: Most of my support system is my family. I socialize, go to work, and take care of my daughter. I have a lot of good days that give me more time to spend with my daughter. VO: We go to the park a lot. We go to what we call our secret park. It's just a smaller park in our town. VO: Having Elodie definitely helps a lot because it does keep my focus on her. She’s my little world. My world revolves around her. And she’s the one that helps me get through things. She gives me all the motivation in the world so that I can be there for her and watch her go through school and go through life and be the greatest person she can be. And I want to watch her grow up and thrive and do good things in life. VO: If you've just been diagnosed with MDD, take your time to be patient. Put one foot in front of the other. It's important to seek help because you can't do it on your own. VO: Talk to your doctor or your health care provider about what you can do to help manage your symptoms. VO: I want to share my story because if there’s one person out there that I can help not feel alone and not feel like they are the only ones that go through this, then that will make me happy. Text on screen Keep watching to see Safety Considerations for VRAYLAR. VO2/Text on screen: IMPORTANT SAFETY CONSIDERATIONS VRAYLAR may cause serious side effects, including: Elderly people with dementia-related psychosis have increased risk of death or stroke. VRAYLAR is not approved in elderly patients with dementia-related psychosis. Tell your doctor about unusual changes in behavior or suicidal thoughts. VRAYLAR and antidepressants may increase suicidal thoughts and actions in some children and young adults, especially in the first few months of treatment or when the dose is changed. VRAYLAR is not approved for people under 18 years of age. Seek medical help right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These may be symptoms of neuroleptic malignant syndrome (NMS), a rare but potentially fatal side effect. VRAYLAR may cause uncontrolled body movements (tardive dyskinesia or TD) in your face, tongue, or other body parts, which may be permanent. VRAYLAR may cause problems with your metabolism, including increased cholesterol or triglycerides, weight gain, high blood sugar, and diabetes. Extremely high blood sugar can lead to coma or death. VRAYLAR may also cause low white blood cell count, decreased blood pressure, falls, seizures (convulsions), sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities, increased body temperature, and difficulty swallowing. Do not take VRAYLAR if you are allergic to any of its ingredients. The most common side effects of VRAYLAR include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. Some side effects may happen a few weeks after starting VRAYLAR or if your dose increases. You and your doctor should monitor, discuss, and report any adverse events if they occur. These are not all the possible side effects of VRAYLAR. Please see additional Important Safety Information on the page below. Please also see full Prescribing Information, including Boxed Warnings, and Medication Guide. LICENSED FROM GEDEON RICHTER PLC. US-VRAA-240104 8/2024 INDICATION AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. VRAYLAR and antidepressants increase the risk of suicidal thoughts or actions in people 24 years of age and younger especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor. VRAYLAR may cause serious side effects, including: Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These can be symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS. Uncontrolled body movements (tardive dyskinesia or TD): VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR. Late-occurring side effects: VRAYLAR stays in your body for a long time. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases. Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR. Problems with your metabolism, such as: High blood sugar and diabetes: Increases in blood sugar can happen in some people who take VRAYLAR. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Tell your healthcare provider if you have symptoms such as feeling very thirsty, very hungry, or sick to your stomach, urinating more than usual, feeling weak, tired, confused, or your breath smells fruity. Increased fat levels (cholesterol and triglycerides) in your blood: Your healthcare provider should check fat levels in your blood before or soon after starting VRAYLAR and during treatment. Weight gain: Weight gain has been reported with VRAYLAR. You and your healthcare provider should check your weight before and regularly during treatment. Low white blood cell count: Low white blood cell counts have been reported with antipsychotic drugs, including VRAYLAR. This may increase your risk of infection. Very low white blood cell counts, which can be fatal, have been reported with other antipsychotics. Your healthcare provider may do blood tests during the first few months of treatment with VRAYLAR. Decreased blood pressure (orthostatic hypotension): You may feel lightheaded or faint when you rise too quickly from a sitting or lying position. Falls: VRAYLAR may make you sleepy or dizzy, may cause a decrease in blood pressure when changing position (orthostatic hypotension), and can slow thinking and motor skills, which may lead to falls that can cause fractures or other injuries. Seizures (convulsions) Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities: Do NOT drive, operate machinery, or do other dangerous activities until you know how VRAYLAR affects you. VRAYLAR may make you drowsy. Increased body temperature: Do not become too hot or dehydrated during VRAYLAR treatment. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Stay out of the sun. Do not wear too much clothing or heavy clothing. Drink plenty of water. Difficulty swallowing that can cause food or liquid to get into your lungs Who should not take VRAYLAR? Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat). What should I tell my healthcare provider before taking VRAYLAR? Tell your healthcare provider about any medical conditions and if you: have or had heart problems or a stroke have or had low or high blood pressure have or had diabetes or high blood sugar in you or your family have or had high levels of total cholesterol, LDL-cholesterol, or triglycerides; or low levels of HDL-cholesterol have or had seizures (convulsions) have or had kidney or liver problems have or had low white blood cell count are pregnant or plan to become pregnant. VRAYLAR may harm your unborn baby. Taking VRAYLAR during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms after birth. Talk to your healthcare provider about the risk to your unborn baby if you take VRAYLAR during pregnancy. There is a pregnancy exposure registry for women who are exposed to VRAYLAR during pregnancy. If you become pregnant or think you are pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/ . are breastfeeding or plan to breastfeed. It is not known if VRAYLAR passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with VRAYLAR. Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider. What are the most common side effects of VRAYLAR? The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. These are not all the possible side effects of VRAYLAR. VRAYLAR is available in 0.5 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, and 6 mg capsules. INDICATIONS AND USAGE VRAYLAR is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) in adults to treat short-term (acute) manic or mixed episodes that happen with bipolar I disorder in adults and children ages 10 years and older Please see the full Prescribing Information , including Boxed Warnings, and Medication Guide . US-VRAA-250457 You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more. HOME ABOUT ABBVIE PRESCRIBING INFORMATION SITE MAP ACCESSIBILITY STATEMENT CONTACT US TERMS OF USE PRIVACY NOTICE COOKIES SETTINGS YOUR PRIVACY CHOICES THIS SITE IS INTENDED FOR U.S. CONSUMERS ONLY. LICENSED FROM GEDEON RICHTER PLC. © 2025 ABBVIE. ALL RIGHTS RESERVED. VRAYLAR ® AND ITS DESIGN ARE TRADEMARKS OF ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, AN ABBVIE COMPANY. VRAYPAY IS A SERVICE MARK OF ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, AN ABBVIE COMPANY. IF YOU ARE A PATIENT, AND HAVE ANY QUESTIONS, PLEASE DISCUSS THEM WITH YOUR DOCTOR OR HEALTHCARE PROVIDER. FOR ADDITIONAL INFORMATION ABOUT VRAYLAR ® , CALL ABBVIE MEDICAL INFORMATION TOLL-FREE AT 1.800.678.1605. US-VRAA-240126 You are now leaving VRAYLAR.com You are leaving the VRAYLAR (cariprazine) site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of VRAYLAR.com or AbbVie. Do you wish to leave this site? YES NO US-VRA-230180 INDICATIONS AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. IMPORTANT SAFETY INFORMATION Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like INDICATIONS AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. IMPORTANT SAFETY INFORMATION Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like INDICATION AND USAGE VRAYLAR is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. IMPORTANT SAFETY INFORMATION What is the most important information I should know about VRAYLAR? Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking medicines like VRAYLAR are at an increased risk of death. VRAYLAR is not approved for treating patients with dementia-related psychosis. VRAYLAR and antidepressants increase the risk of suicidal thoughts or actions in people 24 years of age and younger especially within the first few months of treatment or when the dose is changed. Depression and other mental illnesses are the most important causes of suicidal thoughts and actions. Patients on antidepressants and their families or caregivers should watch for new or worsening depression symptoms, especially sudden changes in mood, behaviors, thoughts, or feelings. This is very important when VRAYLAR or the antidepressant is started or when the dose is changed. Report any change in these symptoms immediately to the doctor. VRAYLAR may cause serious side effects, including: Stroke (cerebrovascular problems) in elderly people with dementia-related psychosis that can lead to death Neuroleptic malignant syndrome (NMS): Call your healthcare provider or go to the nearest hospital emergency room right away if you have high fever, stiff muscles, confusion, increased sweating, or changes in breathing, heart rate, and blood pressure. These can be symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS. Uncontrolled body movements (tardive dyskinesia or TD): VRAYLAR may cause movements that you cannot control in your face, tongue, or other body parts. Tardive dyskinesia may not go away, even if you stop taking VRAYLAR. Tardive dyskinesia may also start after you stop taking VRAYLAR. Late-occurring side effects: VRAYLAR stays in your body for a long time. Some side effects may not happen right away and can start a few weeks after starting VRAYLAR, or if your dose increases. Your healthcare provider should monitor you for side effects for several weeks after starting or increasing dose of VRAYLAR. Problems with your metabolism, such as: High blood sugar and diabetes: Increases in blood sugar can happen in some people who take VRAYLAR. Extremely high blood sugar can lead to coma or death. Your healthcare provider should check your blood sugar before or soon after starting VRAYLAR and regularly during treatment. Tell your healthcare provider if you have symptoms such as feeling very thirsty, very hungry, or sick to your stomach, urinating more than usual, feeling weak, tired, confused, or your breath smells fruity. Increased fat levels (cholesterol and triglycerides) in your blood: Your healthcare provider should check fat levels in your blood before or soon after starting VRAYLAR and during treatment. Weight gain: Weight gain has been reported with VRAYLAR. You and your healthcare provider should check your weight before and regularly during treatment. Low white blood cell count: Low white blood cell counts have been reported with antipsychotic drugs, including VRAYLAR. This may increase your risk of infection. Very low white blood cell counts, which can be fatal, have been reported with other antipsychotics. Your healthcare provider may do blood tests during the first few months of treatment with VRAYLAR. Decreased blood pressure (orthostatic hypotension): You may feel lightheaded or faint when you rise too quickly from a sitting or lying position. Falls: VRAYLAR may make you sleepy or dizzy, may cause a decrease in blood pressure when changing position (orthostatic hypotension), and can slow thinking and motor skills, which may lead to falls that can cause fractures or other injuries. Seizures (convulsions) Sleepiness, drowsiness, feeling tired, difficulty thinking and doing normal activities: Do NOT drive, operate machinery, or do other dangerous activities until you know how VRAYLAR affects you. VRAYLAR may make you drowsy. Increased body temperature: Do not become too hot or dehydrated during VRAYLAR treatment. Do not exercise too much. In hot weather, stay inside in a cool place if possible. Stay out of the sun. Do not wear too much clothing or heavy clothing. Drink plenty of water. Difficulty swallowing that can cause food or liquid to get into your lungs Who should not take VRAYLAR? Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat). What should I tell my healthcare provider before taking VRAYLAR? Tell your healthcare provider about any medical conditions and if you: have or had heart problems or a stroke have or had low or high blood pressure have or had diabetes or high blood sugar in you or your family have or had high levels of total cholesterol, LDL-cholesterol, or triglycerides; or low levels of HDL-cholesterol have or had seizures (convulsions) have or had kidney or liver problems have or had low white blood cell count are pregnant or plan to become pregnant. VRAYLAR may harm your unborn baby. Taking VRAYLAR during your third trimester of pregnancy may cause your baby to have abnormal muscle movements or withdrawal symptoms after birth. Talk to your healthcare provider about the risk to your unborn baby if you take VRAYLAR during pregnancy. There is a pregnancy exposure registry for women who are exposed to VRAYLAR during pregnancy. If you become pregnant or think you are pregnant during treatment, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or http://www.womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/ . are breastfeeding or plan to breastfeed. It is not known if VRAYLAR passes into breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with VRAYLAR. Tell your healthcare provider about all medicines that you take, including prescriptions, over-the-counter medicines, vitamins, and supplements. VRAYLAR may affect the way other medicines work, and other medicines may affect how VRAYLAR works. Do not start or stop any medicines while taking VRAYLAR without talking to your healthcare provider. What are the most common side effects of VRAYLAR? The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. These are not all the possible side effects of VRAYLAR. VRAYLAR is available in 0.5 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, and 6 mg capsules. INDICATIONS AND USAGE VRAYLAR is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults to treat depressive episodes that happen with bipolar I disorder (bipolar depression) in adults to treat short-term (acute) manic or mixed episodes that happen with bipolar I disorder in adults and children ages 10 years and older Please see the full Prescribing Information , including Boxed Warnings, and Medication Guide . US-VRAA-250457 { "@context": "http://schema.org", "@type": "MedicalWebPage", "audience": "https://schema.org/Patient", "specialty": [ "https://schema.org/Psychiatric"], "url": "https://www.vraylar.com/amdd/why-vraylar", "name": "How VRAYLAR® (cariprazine) Is Thought to Work", "description": "VRAYLAR® is an add-on treatment for adults with major depressive disorder. Learn about side effects, dosing, and more. See full Prescribing Info, including Boxed Warnings.", "about": [ {"@type": "Drug", "name": "VRAYLAR®", "nonProprietaryName": "cariprazine", "description": "VRAYLAR is a prescription medicine used in adults along with antidepressant medicines to treat major depressive disorder (MDD), for short-term (acute) treatment of manic or mixed episodes that happen with bipolar I disorder, and to treat depressive episodes that happen with bipolar I (bipolar depression)", "dosageForm": "capsule", "prescribingInfo": "https://www.rxabbvie.com/pdf/vraylar_pi.pdf"}], "potentialaction": [ {"@type": "ViewAction", "name":"Connect with a healthcare provider", "description":"You’ve made progress with your antidepressant, but unresolved symptoms may leave you feeling stuck. Adding VRAYLAR can give it a lift and may help you get where you want to be.", "url":"https://www.vraylar.com/amdd/find-a-healthcare-provider"}, {"@type": "ViewAction", "name":"Create your discussion guide", "description":"Check in with yourself and create a personalized doctor discussion guide for your next appointment.", "url":"https://www.vraylar.com/doctor-discussion-guide"}, {"@type": "ViewAction", "name":"Find support and resources", "description":"Everyone’s journey with depression is different. Get helpful resources and support to help you stay on track with your prescribed treatment plan.", "url":"https://www.vraylar.com/amdd/support"}, {"@type": "ViewAction", "name":"Create your discussion guide", "description":"Check in with yourself and create a personalized doctor discussion guide for your next appointment.", "url":"https://www.vraylar.com/doctor-discussion-guide"} ], "mainEntity": [ { "@type": "Question", "name": "Have you ever tried an add-on treatment, along with your antidepressant?", "acceptedAnswer": { "@type": "Answer", "text": "Yes but I'd like to learn more about VRAYLAR, No but I'm interested in seeing how VRAYLAR may help, No but I would like to learn more about add-on treatment."}}, { "@type": "Question", "name": "What are the most common side effects of VRAYLAR?", "acceptedAnswer": { "@type": "Answer", "text": "The most common side effects include difficulty moving or slow movements, tremors, uncontrolled body movements, restlessness and feeling like you need to move around, sleepiness, nausea, vomiting, indigestion, constipation, feeling tired, trouble sleeping, increased appetite, and dizziness. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of VRAYLAR."}}, { "@type": "Question", "name": "Will VRAYLAR cause weight gain?", "acceptedAnswer": { "@type": "Answer", "text": "In clinical studies, 98% of patients in 6-week trials and 81% of patients in a 6-month trial had no substantial weight gain (defined by ≥7% change). In the 6-month study, the average weight gain in VRAYLAR-treated patients was 3.7 lb. Weight gain may occur. You and your doctor should monitor your weight regularly.VRAYLAR 1.5 mg/day and 3.0 mg/day."}}, { "@type": "Question", "name": "Can I anticipate any sexual side effects when adding VRAYLAR?", "acceptedAnswer": { "@type": "Answer", "text": "In clinical studies, less than 1% of patients taking VRAYLAR with their antidepressant reported sexual side effects"}} ], "video": [ {"@type": "VideoObject", "contentURL": "https://players.brightcove.net/1029485116001/Mcp9TXMkPT_default/index.html?videoId=6334113720112", "description": "Watch our TV ad and ask your provider if adding VRAYLAR to your antidepressant could help you get more symptom relief.", "duration": "T1M0S", "name": "For a lift in relief", "thumbnailURL": "https://vraylar.com/content/dam/vraylar/images/VRAA-ITS-0630/why-vraylar/video--lift-relief2.png", "transcript": "https://vraylar.com/amdd/why-vraylar/for-a-lift-in-relief-transcript", "uploadDate": "2023-10-31"}, {"@type": "VideoObject", "contentURL": "https://youtu.be/RFTAgv-seyI", "description": "Watch our TV ad and ask your provider if adding VRAYLAR to your antidepressant could help you get more symptom relief.", "duration": "T1M0S", "name": "For a lift in relief", "thumbnailURL": "https://www.vraylar.com/content/dam/vraylar/images/VRAA-ITS-0630/why-vraylar/video--lift-relief1.png", "transcript": "https://www.vraylar.com/amdd/why-vraylar/discover-a-lift-in-relief-transcript", "uploadDate": "2023-10-31"}] }